- Home
- BLFS vs HROW Comparison
BLFS vs HROW Comparison
Compare BLFS & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLFS
- HROW
- Stock Information
- Founded
- BLFS 1987
- HROW 1998
- Country
- BLFS United States
- HROW United States
- Employees
- BLFS N/A
- HROW N/A
- Industry
- BLFS Medical/Dental Instruments
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- BLFS Health Care
- HROW Health Care
- Exchange
- BLFS Nasdaq
- HROW Nasdaq
- Market Cap
- BLFS 1.0B
- HROW 1.1B
- IPO Year
- BLFS 1989
- HROW N/A
- Fundamental
- Price
- BLFS $22.10
- HROW $34.53
- Analyst Decision
- BLFS Strong Buy
- HROW Strong Buy
- Analyst Count
- BLFS 7
- HROW 7
- Target Price
- BLFS $30.57
- HROW $61.83
- AVG Volume (30 Days)
- BLFS 479.2K
- HROW 436.0K
- Earning Date
- BLFS 08-07-2025
- HROW 08-11-2025
- Dividend Yield
- BLFS N/A
- HROW N/A
- EPS Growth
- BLFS N/A
- HROW N/A
- EPS
- BLFS N/A
- HROW N/A
- Revenue
- BLFS $87,762,000.00
- HROW $212,858,000.00
- Revenue This Year
- BLFS $21.21
- HROW $46.17
- Revenue Next Year
- BLFS $17.58
- HROW $39.97
- P/E Ratio
- BLFS N/A
- HROW N/A
- Revenue Growth
- BLFS 34.80
- HROW 53.49
- 52 Week Low
- BLFS $19.10
- HROW $20.85
- 52 Week High
- BLFS $29.55
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- BLFS 51.26
- HROW 53.90
- Support Level
- BLFS $21.94
- HROW $35.27
- Resistance Level
- BLFS $22.78
- HROW $37.74
- Average True Range (ATR)
- BLFS 0.89
- HROW 1.79
- MACD
- BLFS 0.11
- HROW -0.15
- Stochastic Oscillator
- BLFS 58.63
- HROW 47.65
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.